Representative Matters
REFERENZMANDATE
代表事项
Life Sciences & Healthcare
- Morningside Ventures on its lead investment of a $50,000,000 Series B funding round into Ieso Digital Health Limited, who deliver high-quality, online cognitive behavioural therapy to NHS patients.
- Jefferies LLC on their at the market sales transaction for up to $100,000,000 American Depositary Shares with Silence Therapeutics plc (AIM:SLN and Nasdaq: SLN), a biotech company developing gene therapeutic technology based on RNA interference.
- Kinnevik on their Series C $100 million investment into Spring Health, a leading global mental health solution.
- COMPASS Pathways plc on its public follow-on offering on NASDAQ of American Depositary Shares for gross proceeds of approximately $144 million.
- COMPASS Pathways plc on its completed upsized $146.6 million NASDAQ initial public offering.
- Omega Funds on co-leading Artios Pharma Limited’s $153 million Series C financing.
- Achilles Therapeutics plc on its Initial Public Offering on NASDAQ with total proceeds of $175.5 million. Achilles is a biopharmaceutical company developing personalised cancer immunotherapies.
- Kinnevik on their Series B $64m funding round in Quit Genius, the world’s first digital clinic for treating nicotine, alcohol and opioid addictions.
- Jeito Capital on leading an oversubscribed $92 million Series C financing round in Artios Pharma Limited, a DNA Damage Response company with a strong pipeline of novel cancer therapies in development.
- Thymia, an online platform which removes subjectivity from mental health assessments, on its series seed funding round.
- Quanta Dialysis Technologies on multiple private funding rounds including its most recent $245 million oversubscribed Series D funding round, the largest private funding round for a dialysis device company in history.
- Lauxera Capital Partners on their investment in LUMICKS, a supplier of Dynamic Single-Molecule and Cell Avidity analysis instruments, as part of a $93 million Series D Financing.
- Arix Bioscience Holdings Limited, a global venture capital company focused on investing in and building breakthrough biotech companies, on the completion of its €1.5 million investment into Twelve Bio ApS as part of its €4 million seed round.
- Morningside Ventures, and early stage venture investor, on the completion of its £23.7 million investment into Immune Regulation Limited as part of a £40.6 million Series B funding round.
- Novo Holdings A/S, a leading international life sciences investor, on its $40 million investment as part of a $60 million Series C funding round into Exscientia Limited, a world leading AI-driven drug discovery company based in the UK.
- Coöperatieve Gilde Healthcare IV U.A., a specialised European healthcare-focused investment fund based in the Netherlands, on its $10 million investment in Big Health Ltd as part of a $25 million Series B.Big Health’s purpose is to help millions back to good mental health, with digital therapeutics - fully automated and highly personalised behavioural programs for mental health.
- Advanced Medical Solutions Group plc, an AIM listed life sciences company, on its acquisition of Sealantis Limited, a developer of an alginate-based tissue adhesive technology platform.
Technology Experience
- Wintermute, a leading global crypto market maker, on their $20 million Series B funding round.
- Kinnevik on their investment into Sure, Inc, an insurtech company.
- Sprout.ai Limited, an insurtech company providing AI to support claims and fraud teams, on its £8 million Series A funding round led by Octopus Ventures.
- DST Global and General Catalyst on a $150 million Series C Financing of Zego, a London, UK-based motor insurtech company, giving it a $1.1 billion valuation and unicorn status.
- Brytlyt Limited, a company that is developing and commercializing GPU-accelerated data processing technology, on its completion of a £3.2 million Series A funding round led by Amadeus V Technology Fund LP and Finch Capital Fund II Cooperatief U.A.
- Joanna Dai Limited, a luxury performance workwear brand specializing in sustainable, versatile and high-tech women’s workwear, on its seed funding round.
- Cognitive Credit, a company developing an end-to-end analytics application that delivers cutting edge technology to institutional credit investors, on multiple private financing rounds including its series A funding round.
- Beyond.Life Ltd, providing an online marketplace that connects funeral directors and at-need customers, on its Series A round.
- Novastar Ventures Limited, an impact investment fund, on its Series A investment in The Sure Chill Company Limited, a company that develops a revolutionary platform cooling technology.
Professional Activities
Ms. McGrath is a member of the British Venture Capital Association.
Ms. McGrath is an Expert in Residence for Women of Wearables.
